Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-006297

Options or other derivatives

  • Chief Financial Officer acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Vu Quan Anh Chief Financial Officer 2025-03-03 Grant or award · Stock Options +25,000 25,000 D: show line 1 in the form
Loading xslF345X05/rdgdoc.xml…